Ultra-rapid purification
of reptilian biomaterials
for use in human tissue
engineering, bone repair
and wound regeneration.
ABOUT US
Lacerta Life Sciences is a commercial stage advanced biologics company fulfilling unmet medical needs in the surgical, orthopedics, wound repair and engineering industries. We have developed innovations around the purification and method of use of novel and proprietary biomaterials.
Our products are not yet for sale in the USA, but currently we are entertaining strategic alliances and partnerships in various fields of reconstructive surgery and tissue wound healing.
TO CONTACT US FOR MORE INFORMATION AND COLLABORATION OPPORTUNITIES:
WOUND CARE
ORTHO
ANIMAL MEDICINE
SPINE
RESEARCH
LACERTAMATRIX™
HYALURONIC ACID FOAM DRESSING
A biologically compatible esterified reptilian derived hyaluronic acid (HA) with a silicone top layer.
Reptilian HA has a strong net negative charge that makes it an ideal scaffold to protect cells and labile growth factors thereby promoting cell proliferation and angiogenesis. It is a chemically crosslinked HA with a serine benzyl ester using the zero-length crosslinker EDC (N-(3-dimethylaminopropyl)-N’-ethyl carbodiimide and NHS (N-Hydroxysuccinimide), engineered to deliver longer wear times in the wound bed. The HA forms a gel once placed in a wound and the biomaterial is resorbed over time, while providing protection from contamination, continuously cleansing wounds and balancing moisture. The silicone layer can be removed prior to application or later in the healing process without damaging the wound bed or discomfort to the patient.
INDICATIONS FOR USE
ACUTE WOUNDS
CHRONIC WOUNDS
DRAINING WOUNDS
DIABETIC ULCERS
PRESSURE ULCERS
SECOND-DEGREE BURNS
SUPERFICIAL WOUNDS
SURGICAL WOUNDS
TRAUMA WOUNDS
VENOUS ULCERS
TECHNOLOGY
Lacerta Life Sciences has developed a very broad patent portfolio that covers the ultra-rapid purification of reptilian biomaterials for tissue engineering and hard (bone) and soft (wound) repair and regeneration (U.S. Application No. 62/942,104).
Preliminary evidence suggests that scaffolds of reptilian Hyaluronic acid (rHA) are high molecular weight (>2mDa), extremely charged, and are ideal for biomaterial engineering that could be incorporated into several medical devices and pharmaceutical products.
ADDITIONAL PROVISIONAL PATENT APPLICATIONS ARE PENDING
MANAGEMENT
KEITH O’BRIANT
CHIEF EXECUTIVE OFFICER
Mr. O’Briant is a seasoned professional with over 30 years of effective leadership in the Life Science industry where he has accumulated an impressive track record of success in the Pharmaceutical, Biologic, and Device sectors. Prior to joining Lacerta Life Sciences as CEO, Keith spent twenty plus years with Pfizer and Shire where he served in numerous leadership roles including Vice President of Sales and Marketing as well as Senior Vice President of Commercial Operations. Mr. O’Briant has also been on the Executive Leadership Teams that launched and built two start up organizations that produced exits in excess of $750M. Mr. O’Briant also founded The Heron Group. The Heron Group is a consulting company focused on serving the life science community as well as start-up organizations in growth sectors. The Heron Group quickly established a stellar reputation by leveraging its experience and delivering strategic growth plans for start-ups as well as fortune 500 companies. Mr. O’Briant earned a Marketing and Management degrees from the University of Louisiana and has completed post graduate work at Harvard Business School and the Kellogg School of Management.
TED BUNDRICK
VICE PRESIDENT OPERATIONS
Mr. Bundrick serves as the Vice President of Operations for Lacerta Life Sciences and has been a member of the Executive Leadership Team with the company since its inception. Ted is responsible for the management of Lacerta’s supply chain operations, which spans from first-stage material processing in Louisiana to partnering with manufacturing facilities throughout North America. Prior to joining Lacerta, Mr. Bundrick served in a leadership role with several multinational organizations in which he was responsible for Warehousing/ Distribution, Quality, Production, Planning, Safety, Processing, and Maintenance operations. Mr. Bundrick has over 20 years of process manufacturing and continuous improvement leadership experience, guided by Total Productive Maintenance principles. At one stage of his career, Ted was invited to tour and consult with Japanese manufacturing firms on Safety & Continuous Improvement principles. Ted is a graduate of the University of Southwestern Louisiana, earning a BA in Liberal Arts. Ted also completed his Master of Business Administration from Loyola University in New Orleans.
Mitchell Sanders, PhD
CHIEF SCIENTIFIC OFFICER
Dr. Mitch Sanders is a serial entrepreneur and in the past 15 years he has secured over $50M in strategic financing for new product development for his lab, mostly in advanced wound care. Mitch as over 35 years of experience in preclinical animal models and clinical product development in advanced wound care. He has produced over 13 peer-reviewed publications and 40 worldwide patents in medical devices, drug delivery, and in vitro diagnostics. He is an expert in clinical and translational research and is a reviewer for Wounds International, Wound Repair and Regeneration and Tissue Engineering, Mitch is a senior member of Wound Healing Society (WHS) and is chair of the Communications Committee. Mitch has BS in Biology with a Minor in Latin Language and Literature from Boston University, an MS & PhD from WPI in Molecular Biology and Biomedical Sciences, and Postdoctoral training in (Biochemistry and Pathogen Genetics) at the Whitehead Institute/MIT.
CONTACT
The Lacerta Life Science business development team is available to assist you with reptile derived hyaluronic acid (rHA) biomaterial needs for new commercial development of advanced medical and pharmaceutical products.
Corporate Headquarters
12906 Community Road, Abbeville, LA 70510
Manufacturing Facility
1169 Wall Road, Broussard, LA 70518
Phone
(678) 334-1286
For any general inquiries, please fill in the following contact form:
